USP starts field trials of FDA fake drug screening device
CD3 imageThe US Pharmacopeial Convention has started field testing a new low-cost screening device designed to detect counterfeit and poor quality medicines quickly. The handheld CD-3+ unit – originally developed by the US Food and Drug Administration (FDA) – uses multiple light sources to look at packaging using different wavelengths and provide images that can be interpreted by the user to differentiate between genuine and falsified medicines. The approach may also be applicable to individual tablets.
USP and the Center for Pharmaceutical Advancement and Training (CePAT)- which was launched last year to equip national and local regulatory authorities in Sub-Saharan Africa with the knowledge and skills to promote access to quality medicines – will carry out the field trials.
Related Posts
Traders get Supreme Court notice on imported Samsung goods
The Supreme Court has issued notices on a complaint filed by South Korea's...
Kochi: Police seize fake currency worth Rs 1.8 crore, 5 arrested
KOCHI: Kochi city police and the anti-terrorism squad (ATS) of the state police...
BASF Introduces New Anti-fake Technology to Tackle Counterfeit Crop Protection Products in China
In China the company is introducing an innovative product label that features an...
China’s appetite for bird nests leads smuggling to take flight
Beijing - With China in the grip of a harsh winter, the demand for edible bird's...